• Tidak ada hasil yang ditemukan

Al Hammadi

N/A
N/A
Protected

Academic year: 2023

Membagikan "Al Hammadi"

Copied!
58
0
0

Teks penuh

(1)

Al Hammadi

Development & Investment

2 0 2 1

THE ANNUAL REPORT

OF THE BOARD OF DIRECTORS OF THE COMPANY

AL HAMMADI FOR DEVELOPMENT & INVESTMENT

(2)

Word of the Chairman of the Board of Directors

Introduction to the company

Community service and social responsibility Policyof remuneration and allowances for the Board members Statement of Cash Flows

Profit distribution policy

Historical profits for previous years

Equity and debt instruments activities

Statement of the debt owed by the group

Risks that the group could face

Disclosure policies

Approval of the members of the Board of Directors

ownership structure for individuals and institutions

Chairman's Closing Statement Policy of remuneration and allowances policy for the

executive management.

Opinion of the external auditor of the company on the annual financial statements

Record of the association attendance during the year

Governance of the company

Reviewing the company’s results for the last five years

Reviewing total assets, liabilities and shareholders' equity for the last five years

Internal audit department

Policy of remuneration and allowances for members of the audit committee

Policy of remuneration and allowances policy for members of the Remuneration and Nominations Committee

Organizational structure of the company Board of Directors

Board meetings in (2021 G)

CVs of the members of the company’s board of directors

Membership of board members in other companies

Board committees Review Committee

Nomination and Remuneration Committee

Ownership of board members and senior executives.

Company's main activity

Vision Mission

Strategic plans

Branches and subsidiaries Al-Hammadi Hospital - Al-Olaya Al-Hammadi Hospital - Al-Suwaidi Al-Hammadi Hospital - Al-Nozha Support Medical Services Company

Quality and Accreditation certificates

(3)

   ­  € €‚  ­ƒ„

€„€€…†„  ‡

 ­‚

(4)

…ˆ ­‰Š‹Œ ށ  ‘‹’ ­’­“‹†

­”’ •’  “Œ  …€ˆ   ‚

   ­•’ ”’­“‰†­–’ ”’  ŠŒ…

ˆ—•­”’˜™­”’ ‰’­“‰†­”’ ‰’  ŠŒ…€ š›

 € €…† †

 †ˆ­ ­ ­‰”–­“•’ ’­“‹†­•’ “’  “Œ‚ ’ –’­“•‹†­‰’ ‹’ ­“Œ

 ˆ  ›  €    ˆ –‹      ˆ † … ‚‹  

† ˆ œ†—™…­­’ ”’ ­“Œ­–’ ”’ ­“Œ‚„… 

›—… ™­–’ ‰’­“•‹†­‹’ –’ ­“Œ‚

€ €„…   —­„ Š™ˆ‚ˆ†

 †ˆ„… …ž

Ÿƒ €…ˆ …‘ ‡ †—­’•­’ ­Œ™Ž ‡€

†‡ †‚

COMMERCIAL REGISTRY

1010374273 1010203580

1010610529 1010374269

1010500366 1010651084 1010899779

1126105966 1010170194

STATUS

Exercising the work activity Exercising the work activity Exercising the work activity

Exercising the work activity Exercising the work activity Exercising the work activity Exercising the work activity Exercising the work activity

Not Exercising the work activity Not Exercising the work activity

Exercising the work activity Exercising the work activity -

-

- BED CAPACITY

-

- - -

- - (300 Bed) (428 Bed) (600 Bed) 1010263026

1010934227 1010374270 Al-Hammadi for Construction & Maintenance

The Support Medical Services Company

Al-Deyafa Al-Arabia Ltd.

Al-Hammadi Company for the managing & operating the hospitals

The Support Services Institute for Training The Women Support Services Institute for Training

Pharmaceutical Services Company Ltd.

The Biological and Pharmaceutical Industries Complex

THE NAME OF THE BRANCH / COMPANY The Companies

The Branches

Al-Hammadi Hospital - Al-Olaya branch Al-Hammadi Hospital - Al-Suwaidi Branch

Al-Hammadi Hospital - Al-Nozha Branch

(5)

VISION

ŸŒ¡

¢¢£Œ‚

(6)

MISSION

Ÿ¢˜

¢

Œ

„˜¤¤¤

(7)

…›†›œ € 

€€†€› €

¥ ¦  „ €

€ €‚ …† ˆ

€† ž

—Œ ­™„§ ¨…€ˆ

„…ˆ€ € ˆ

 ›…ˆ¨€†

†€ € ˆ

„›†£†§€— • Œ™

 †—  Œ™€…††

ˆ©€†ƒ 

†€‚†

€ ˆ œ†¨€†‡

„€†

€ ‚

(8)

1 2 4

9 8 7 6 5

3

















 ­€

‚



ƒ‚

„

„€



(9)

ށ Œ„… ˆ

„€…† €

 €  „

… † ˆ  €„  ˆ„

 †„ˆ€

 …ž

   ˆ  

¥ ­ˆ§

††© ’ ‰’­““•† ‰’­”’ ­

(10)

 €

€€† „

­”ˆ„ ­…   ‚… … •  

ˆ­  ‚… €†  €„

„… € †„

©„ˆ 

300

- 120

Outpatient Clinic

Buildings Bed

(11)

 …„ Ž…

„ˆ † —”ª™

ˆ€†—•™†ª„

ˆ—•™ ˆ † „……

—­ ’­ ’­“•”Ž† ­’ Š’ ­‹Œ™„

—“Šˆ™Ž—”“™ ‚

428

9 64

Outpatient Clinic

Buildings Bed

(12)

ށ Ž Ž«ˆ 

    Ž «  … †

— ’­•’ ­Š Œ™‚  ˆ †     —”™

ªˆ€†…†ª

 Žªˆ †›†‚ —”  ˆ™

—”“™ ‚

600

8 64

Outpatient Clinic

Buildings Bed

(13)

ށ€ €¥— ­’•­’ ­ŠŒ™

† €‚„… «

€† ށ †€  

„€† ށ €„ˆ

 †„ †ˆ††‚  ›†‚

2,000,000

SAR

% 100

…† ‡ˆ‰Š

ށ€ €¥— ­’•­’ ­ŠŒ™

—¢™ €‚

 «…   €‚

…† ‡ˆ‰Š

‹

„ ƒŒ

name of the company

capital of the company

Ownership Percentage

Its main activity

„

500,000

SAR

% 100

‹

„ ƒŒ

name of the company

capital of the company

Ownership Percentage

Its main activity Its headquarter Its headquarter



†Ž Œ „‘Œ’‘

‰

(14)

SAUDI CENTRAL BOARD FOR ACCREDITATION OF

HEALTHCARE NSTITUTIONS - CBAHI

UNITED INTERNATIONAL COMMITTEE FOR THE ACCREDITATION OF HEALTH

ORGANIZATIONS

AMERICAN SOCIETY FOR HEALTH INFORMATION MANAGEMENT SYSTEMS

ACCREDITATION

ACCREDITATION OF THE AMERICAN SOCIETY

OF PATHOLOGY

Health Services Board Decision No. (8/58) was issued on (09/01/1433 H - corresponding to

05/12/2011 G), which stipulates that it is necessary to obtain the approval of the Saudi Central Board for accreditation of health facilities for all governmental and

private health facilities, and it is valid.

It is one of the most important international organizations that

specializes in providing innovative pioneering solutions

to help global health care organizations in all locations to

improve patient safety and quality in the field of health

services.

It is an American organization dedicated to improving healthcare in terms of quality,

safety, cost-effectiveness and accessibility through the best use

of information technology and management systems.

The College of American Pathologists (CAP) is a medical

facility that serves more than (17,000) physicians and laboratories around the world. It is the world's largest association

consisting exclusively of pathologists and is widely recognized as a leader in the

field of medical laboratory quality assurance.

‡ˆˆ  ˆ„…† € €

€‚



 ­€­­

(15)

€ˆ …   …†† €†

¨„ˆ ˆ‚›† ˆ€… €„… «

…›ˆˆ„ ˆˆ „…€€ €

ˆ…„ …ž

¢† 

…ˆˆ † ª‚

†‡ …€†

€ €€„…

¨ „ ˆ†

§†…›€ ‚

†   † †« ˆ

 € …

€ †€€‚

 † 

 €€

ƒ €†ˆ ‚

†     ƒ

€ ˆ›†€

  † † ¥ …

ƒ‚

† €    …›

…››…¥

 †† ˆ €ˆ

†  „  †ž Ÿ

„„ˆ„†„ˆ 

„Œ ˆ „ „Ÿ

 „  „Ÿ †Ÿ›„

„Ÿ ‚

­€‚†  …

€ ˆ‚

‚†     †

 ‚

€ƒˆ†…†‚

(16)

 € €—‰™ˆ„©…ލ€

ˆ„‡€—‹™…ˆ‚ˆ†¨†‚

Ÿˆ¦ Œ ˆ „ … 

†  …›    „      ‚  €

€†  ƒ†€‚† ‡ˆ ›

‚¨€††…¨€¨††› ˆ

†…†¦……›€ˆ‚ 

ˆ…€ €† ‚

 …†‡†…†« ž

Œ

¬

ŒŒ

’

Œ

Œ

Œ

Œ

Œ

¢

Ž

ŽŸ

Ž

Ž¡

ŒŒ

Œ

¢

Œ

˜

Œ

Œ

£

Œ

Œ

¢

(17)

2019/6/22 2019/6/22 2019/6/22 2019/6/22 2019/6/22 2019/6/22 2019/6/22 2019/6/22 2019/6/22

NAME

‚’ ށ

‚’ˆ «« ށ

‚’ ށ

‚’ˆ «« ށ

‚’ˆ › Ž

‚’ˆ ««ˆ ˆ 

‚’«« Ž˜

‚’ ˆ Ž

‚’ˆ ށ

 ށ€ €ˆ„…‡€ˆ

…¨€„ލ€ˆ† ‚—­Š™

€„…€†‚€ ‚­€†‚­‡† ˆ„„…

„…€ €†‚€ ­€†‚­‡†‰­†€€ „„…Š€†‚­ƒ€

JOB TITLE & Position MEMBERSHIP DATE OF HIRING





††

ˆ

ˆ

ˆ

ˆ

ˆ

ˆ

ލ€ˆ

ލ€ˆ

¨€ˆ

¨€ˆ

¨€ˆ

¨€ˆ

¨€ˆ

¨€ˆ

¨€ˆ

(18)

2021/03/25 2021/08/12 TOTAL 5 5 5 5 5 5 5 5 5 2021/09/16

2021/05/05 2021/11/11

2021/11/11 2021/03/25

 —‹™††—Œ ­™Žˆ… …†ˆ ž

… ˆ† †Ž

†„††‚ …†ˆ …ˆ „…—™

‚

‹ŒŽŒ‘’

NAME

‚’ ށ

‚’ˆ «« ށ

‚’ ށ

‚’ˆ «« ށ

‚’ˆ › Ž

‚’ˆ ««ˆ ˆ 

‚’«« Ž˜

‚’ ˆ Ž

‚’ˆ ށ

NAME

‚’ ށ

‚’ˆ «« ށ

‚’ ށ

‚’ˆ «« ށ

‚’ˆ › Ž

‚’ˆ ««ˆ ˆ 

‚’«« Ž˜

‚’ ˆ Ž

‚’ˆ ށ

(19)

— ­‰’ ”’Œ™

“

NAME

Œ

˜

®

NAME

Œ

˜

®

NAME

Œ

˜

®

NAME

Œ

˜

®

”•– ”•





†

««† €

 

€ €

— ­‰’ ”’Œ™

¢



¢ 

€ €

  ’ —­‰–‰Ž­‰Š™

  

Ž£ŽŽ¢

”•

”•

— ­‰’ ”’Œ™

††



 €€ 

€€

—™  ”Ž  ‰

ˆ   –Ž  ‰

Ÿˆ€

—­‰‰”Œ™

 ›†Ÿˆ€„—­‰‰”Œ™

— ­‰’ ”’Œ™

ˆ†¦



Ÿ›£†£ € —  “ŒŽ  ‹Œ™

Ÿ›£†€ —  ‹ŒŽ  ŠŒ™

 Œ † Ž«€

(20)

“

NAME

Œ

˜

®

Œ

˜

®

— ­‰’ ”’Œ™

ˆ ««   †



 †š 

š’ˆ€Ž—­“–Ž  ”Œ™

 „ˆ€—­“ Ž   Œ™

ˆ˜ 

†¦Ž

Ÿ›Œ ŽŒ —­“­”Ž­‰‰‹Œ™

— ­‰’ ”’Œ™

 €€£ †



†’£†€  ŽŒ —   Œ™

 †’£†€  —­‰‰“Œ™

 † Ž ­ …

 €€› †Ž    ­

¨€¦ € 

€Ž ­–  ­‰

¢  „ †¯—€ ™

 † Ž ­­  ­‹

¨€ ›†ŒŽ  –  ­ 

¨€ †  Ž  “   –

  Ž  ­   “ Ž­‰‰“   

”• NAME ”•—

NAME

Œ

˜

®

— ­‰’ ”’Œ™

Œ †Ž



€ †€€

‡ Ž

 ©†… €

 §†£†€

Œ  €Ž ­‰

Œ †€Žˆ € ­– ­‰

€Žˆ€ ­­  ­–

”•

(21)

“

NAME

Œ

˜

®

— ­‰’ ”’Œ™

–

Œ †Ž Ž¡ ސ



 §†† €„

Ž¡ Ž€ŽŒ †— ­“ŒŽ …™

ށ 

—  ‰ŒŽ ­“Œ™

¬ŒŽ›—  –ŒŽ  ‰Œ™

Žš£Ž¦—  ”ŒŽ  –Œ™

ŸŽ¨ —  ‹ŒŽ  ”Œ™

NAME

Œ

˜

®

— ­‰’ ”’Œ™

”•–

¨€Ž Ž



ŽŒ —  •Œ™

 Ž…›€ŽŒ —  ­Œ™

  †£†€ŽŒ —­‰‰”Œ™

¨€…€ €Ž

—  –ŒŽ ­Œ™

 ˆˆ  Ž—  ­ŒŽ  –Œ™

   —­‰‰ŒŽ  –Œ™

(22)

£†…ˆˆˆ€ˆ

†ž

1

3 2

4

5 6



NAME COMPANIES THAT ARE MEMBERS OF

THEIR BOARDS OF DIRECTORS OR OF THEIR DIRECTORS HEADQUARTER LEGAL ENTITY CURRENTLY / PREVIOUSLY

ށ ««† € ›† ©Ž›  

‚’«« Ž˜ šŽ † ›† ©›  

‚’ˆ › Ž

›† ©Ž›   …€ 

›† ©› € 

ˆ†

‚’ˆ «« ށ

‚’ ށ

›† ©› € 

  ‚

›† ©›   Ž€€ 

›† ©›  

†‚

›† ©Ž›  

««† €

‚’ˆ «« ށ

›† ©›   Ž€€ 

›† ©› € 

««† €

›† ©› € 

€€¥Ž

›† ©› € 

 

(23)

NAME COMPANIES THAT ARE MEMBERS OF

THEIR BOARDS OF DIRECTORS OR OF THEIR DIRECTORS HEADQUARTER LEGAL ENTITY CURRENTLY / PREVIOUSLY

 ˆ Ž

ˆ ށ

ˆ ««ˆ ˆ ސ

š ˆ š›  

š€

›† ©Ž›  

œ

›† ©Ž› € 



›† ©Ž› € 

ˆŸ†

ˆ

›† ©Ž› € 

ˆ€ 

€ 

›† ©Ž› € 

ˆ 

€Ž

† ©Ž› € 

 

›† ©›   Ž€€ 

›† ©› €  Ž¡ Ž€

›† ©›   Ž© †

7

8

9



(24)

 §†„

„‡€ ‡›ˆ †„

…›… ‚—­–™ ˆ

† ‚—­‰™…ˆ‚ˆ„†„¨ˆ 

ˆ› €ˆ ¥…†ˆ‚† 

† …ƒŒ€„……€ˆŒ

ˆ  —­’”’ ­–ŒŽ† “’ Š’­“•‰™„…† „ €…

ƒ¥‚

ˆ„ …†ˆ … ‡ˆ‚ „

ˆˆ…ˆ …ž

 …†ˆ …§—Œ ­™Ž —Š™† …ž

NAME MEMBERSHIP STATUS IN THE BOARD THE POSITION ON THE COMMITTEE

‚’«« Ž˜ ˆ 

‚’ˆ ««ˆ  ˆˆ ˆ

‚’ˆ ށ ˆ ˆ

2021/04/07

2021/03/24 2021/05/05 2021/06/14

8 7

×

8 NAME

‚’«« Ž˜

‚’ˆ ««ˆ 

‚’ˆ ށ

TOTAL

2021/12/26 2021/11/09

2021/09/14 2021/08/11

(25)

†  ‡ ˆ

ˆ†¨†

†††„‚

­€‚¨ Ž†ˆƒ¥Ž

…ˆ‡ 

„ˆ ˆ „  …

€€ ‡ „„ˆ

†‚

‚¨  ‡ ‚

€ƒ† ˆˆƒ‡

†„…€„ƒ ¦„‚

 ¢†† ‡

‚

††  …†€†

†‚

€…† † €†

›†‚

­€‚¢†ƒ … € …„† „ 

‚

‚€…†ˆˆ

… „ˆ€…‚

€ƒ†…€›†

ˆ¨‚

†€…†ƒ ‡  ›

†‚

­€‚¨†  …† 

€ˆ€‚

‚ †€†€ 

€€ ˆ 

œ€†…››†‚

€ƒ† 

†††‚

†ˆ „

†€ †„€†

€…†…›†

…‚

­€‚¢† ƒ „ ˆ©€„ „ œ€ 

…›„›† € ‚

‚€…†ƒƒ ˆ„€†

€…›ˆˆ…›„

¨† ††‚

€ƒ…†ˆƒƒ¥‚

 †ƒ‡

 …†…ˆ›†‚

(26)

ˆ €…†Ž

›††††

ˆ€ † €ˆ

¨€†„…

€ œˆ¨€

 † ‚—•™

 …†ˆˆ… …†ˆ „

 †— ­Œ™Ž…†ˆ ˆ

—’ •’ ­Œ™Ž—‰’­’ ­Œ™

„††˜†™…ƒ†€‡„‚€

† ˆ

†¨€†

ˆ†€

ˆŒ ˆ „€ › …†

„ €‡ ‚

­€‚ † ˆ…†

ˆ  „† € ‚

‚€…† „€ œ€

€†ˆ©€†‚

€ƒ†ˆˆ

ˆ„†„ƒ

¨€„…€ ‚

 ††† ˆ

¨€†‚

†ˆ

ށ…€ „›†

€ €ˆ‚

†ˆ ¥ ‡¥

ˆ†¨€†‚

†ˆ …›ˆ

‚

  €…    ›  ¨ 

ˆˆ¨€†‚

€…†¨€†

›†††ˆ‚

‡¢† ˆˆ

ˆªˆˆˆ

‚

š‡ ˆ †©ˆ¨€ˆ„ލ€ˆ„

ˆ¨€‚

ˆ †       ˆ 

ˆ¨€€‚

€ƒ† …› †  ˆ  „

†  …ƒ‚

NAME

‚’ˆ › Ž

‚’ ˆ Ž

‚’ˆ ށ

MEMBERSHIP STATUS IN THE BOARD

THE POSITION ON THE COMMITTEE

ˆ 



ˆ

ˆ

ˆ

ˆ

(27)

MEMBERSHIP STATUS (01/01/2021 G) (CHANGES IN SHARES +/-) (Percentage Change %)



ލ€ˆ

¨€ˆ

¨€ˆ

ˆ

ˆ

ˆ

ˆ

ˆ

15.787.800 17.880.000 5.880.000 5.880.000 2000 0 0 15 1009

15.787.800 18.940.100 5.880.000 5.880.000 2000 0 0 15 1009

1.060.100

% 0 % 0 % 0 % 0 % 0 % 0 % 5.93

% 0

% 0 (31/12/2021 G)

NAME

‚’ ށ

‚’ˆ «« ށ

‚’ ށ

‚’ˆ «« ށ

‚’ˆ › Ž

‚’ˆ ««ˆ ˆ ސ

‚’«« Ž˜

‚’ ˆ Ž

‚’ˆ ށ

5,880,000 5,880,000 0.0 0.0 0.0

%0

%0

%0

%0

%0 5,880,000

5,880,000 0.0 0.0 0.0

 …†ˆ …†…ˆˆ¨€„ †…€ „ˆ

„††‡ — ­Œ™‚

†€šŠ€ …€†‚„„…

†€šŠ€ …€†‚„„…

›

MEMBERSHIP STATUS (01/01/2021 G) (CHANGES IN SHARES +/-) (THE PERCENTAGE %)

¨€ˆ

(31/12/2021 G)

NAME

‚’ ށ

¨€ˆ

‚’ˆ «« ށ

 ¦

  ‡

›†

‚’Ÿ ˆ £ ¥ Ž£…



© ށ

+

(28)

THE MEMBER REMUNERATIONS BOARD OF DIRECTORS

Ÿ

Ÿ

Ÿ

®¢ŒŸ

(29)

1 2 3 4 5 6

……ƒ „ˆ… ˆˆ

Œ ˆ …¦ ˆ†… …

 … † ‚¨€†„…¥

Œ€† £†ˆˆ › ‚— Š’­”’ ­–™Ž— ‹’­”’­“•Š

†­•’ ’ ­–Œ™ˆ…Ÿ ‚—’•™Ž— ­’Š’­“•–Ž†­­’­­’ ­‹Œ™

ˆˆ ˆ…   

ƒˆ ……¦ †„€ …ˆˆ

€ˆˆ¨—‹  „   ™‚—€™

‡ Ž›ˆ‡

 …†—‹„   ™—‡€™ …†

—‹„   ™ˆ‚

‡Ž ›„„ށˆ…† › ‚

 „ ˆ ¨ „

›„„…œ‚

„ … …‡ „ˆˆ

ˆˆ‡ „ ˆ‚

  ˆ†ˆ†

(30)

1 3 5

2 4 6

 ˆ—‹ „   ™Ž—‡™

ˆ†

ˆ‚

 …    †  —‹„   

™ Ž —‡€  ™    

ˆ‚

ˆ

  ‚  ˆ 

¨ § †„  ›„

„  †

§…›‚

  ˆ

†ˆ†‚

ˆŽ € ›„  

ށˆ†

„  … …

‡ „€ˆŽ

ˆˆ

‡ „ ˆˆˆ

‚

1 3 5

2 4 6

 ˆ—‹ „   ™—‡™

    

ˆ†ˆ‚

 …†—‹„   ™

—‡€™

ˆ†

ˆ‚

ˆ

  ‚  ˆ 

¨ § †„  ›„

„  †

§…›‚

  ˆ

†ˆ†‚

ˆŽ € ›„  

ށˆ†

„  … …

‡ „€ˆŽ

ˆˆ

‡ „ ˆˆˆ

‚

(31)

ˆ  

… ƒ  † Ž ˆ

ƒ Ž† …

 …Ž …

 ˆ Ž  ¨ „ ˆ

Ž— 

 Ž  …›

©„  ˆ „

…›™

  

 ¨€ †

† € ˆ



 › 

 † € 

†

  †  € Ž 

€ ›Ž€€¯

†

  ¨€ € ˆ

¬‚

(32)

The certain amount The Allowance for attending the board sessions Total allowance for attending the committee sessions The Non-monetary advantages The Remunerations of theMeridional works The Fixed, administrative andinvestment Remunerations The total is in SAR The percentage of profits The Periodic Remunerations The Short-term incentive plans The Long-term incentive plans The shares granted are the value entered Total The Grand total in SAR The Expense allowances The Indemnity

The Fixed Remunerations The Variable Remunerations

ˆ

ލ€ˆ

- - - - -

- - - - - -

- - - -

- -

- - -

-

- - -

- - - -

¨€ˆ

- - - -

- - - -

The name

- - - - -

- - - - 200,000

200,000 200,000 200,000 200,000

- - - - -

- - - - -

210.000 235.000 240.000 210.000 210.000

- -

- -

­‚ƒ „……†…………

­‚„…‡ ‡„…ƒ„………­ˆ

­‚‡ ‡ƒƒ…  

­‚… ƒ„…ƒ…

­‚„……ƒ  

­‚…ƒƒƒ…ƒƒ 

­‚„…‡ ‡ƒƒƒ…ƒƒ 

­‚ƒƒ…ƒƒ…ƒƒ 

­‚„…‡ ‡…ƒƒ…ƒƒ 

210.000 235.000 240.000 210.000 210.000 10.000

35.000 40.000 10.000 10.000

(33)

1.658.221 5.551.549 7.390.865 350,000 7,740,865

SAR SAR

1.839.316

SAR SAR SAR SAR

3.893.328

SAR

40,000

Members of the Audit Committee

35,000 40,000 50,000

50,000 50,000

90,000 85,000 90,000

Fixed remuneration - except for the session attendance allowance

10,000 10,000 10,000 50,000

50,000 50,000

60,000 60,000 60,000 Senior Executive Jobs

THE NAME FIXED REMUNERATION - EXCEPT FOR THE SESSION ATTENDANCE ALLOWANCE

ALLOWANCE TO

ATTEND SESSIONS TOTAL

THE NAME FIXED REMUNERATION - EXCEPT FOR THE SESSION ATTENDANCE ALLOWANCE

ALLOWANCE TO

ATTEND SESSIONS TOTAL

The Fixed Remunerations The Variable Remunerations

PUNISHMENT / PENALTY AND PRECAUTIONARY MEASURE

RESERVE ENROLLMENT

THE SIGNATORY OF THE VIOLATION

‡…‡‘

‡…‡‘

WAYS TO TREAT IT

‡…‡‘

REASONS FOR THE VIOLATION

‡…‡‘

›

™

payroll Allowances The Non-monetary

advantages Total PeriodicRemunerations Profits Short-term

incentive plans Short-term

incentive plans Granted shares Total fixed

and variable

Remunerations Indemnity Total executivesremuneration for

the board - if any - Total

Five senior executives, includ- ing the Chief Executive Officer and the Finance Manager

 ƒ“

Š”‡Ž ƒ„

Š” Œ •

Š”„ Š „

„  ƒŽ

•„ Œ ƒ‡

(34)

†……¨ „‚¡¬…

†  ‡ †‡ †—•­’­’ ­Œ™ …ž

  ‡  †  „   „   ‡   †

—­’•­’ ­Œ™Ž ‡  ª……

  †€£†ˆ‚ˆ €ˆ

†«‡ˆ ‚

ˆ©€€€€†ƒ†

€ ‚ €†ˆ©€ˆ€†† € €œ€

›†„ „€ €€‚ƒ 

 €…„†€©ˆ…†›…›¦œ€

ƒ „ †   € ˆ ›  …   ˆ€     

€€€ˆ›‚

  €ƒ† œ€ ¦   ˆ

‡ „ … …„†  „… † ›œ›€†

† „   †€††ƒ‚

†ˆ †€œ€ … € ›

ˆ¨…ˆ „…†€ˆ €

 ‚ €…†ˆ ¨ €

   „ˆ…  €…€…„€

€ «   

›…€ ‚…›€„›†ˆ…† €ˆ

† †ƒ…›„… €€…€  €…

 €  ˆ©€€†¦†œ€

… † € …† ‚

›œ

(35)

‚’ ށ

‚’ˆ «« ށ

‚’ ށ

‚’ˆ «« ށ

‚’ˆ › Ž

‚’ˆ ««ˆ ˆ 

‚’«« Ž˜

‚’ ˆ Ž

‚’ˆ ށ

NAME JOB TITLE IN THE COMPANY ORDINARY GENERAL ASSEMBLY MEETING 19/05/2021

ORDINARY GENERAL ASSEMBLY MEETING 09/12/2021

THE DATE OF APPLICATION

2021/12/14 2021/06/02 2021/06/02

REASONS FOR THE REQUEST

Œ

Œ

Œ ˆ 

›œ

‹ŒŽŒ‘’

¨ „‚’¡¬€ˆ  ‡ Œ‡

†—•­ˆ ­Œ™‚





††

ˆ

ˆ

ˆ

ˆ

ˆ

ˆ

(36)

€ € †€  

€ˆŒ ˆ  —­’”’ ­–Œ™ˆ € „…

€† ƒ‡  † ‚

‡  …†† ˆ€ † …†ž

€ˆ†€ 

ˆ ˆ ‚

­€‚ † œ€ €   … ¨€

 €    „  †

€„›† …‚

‚ … ¨œ€

  ›†‚

€ƒ€ € † „

 † …†ž

” †€‡ˆˆ‚

” †ˆƒ ¥‚

” † §ˆ  ˆ

€‚

” †‚

” †€ˆ‡ ˆ 

…†ˆˆ‚

” †¥¥…

ª…‡ ›

† ‚

Œ€† ‚

­€‚† † ˆ  ‚

‚† ‚

€ƒ† ‚

  † ‚

   ˆ‚

 † ‚

 † ›†‚

 † €†‡‚

† …› ‚

‡ ª ‚

­€Š€†€†­ˆ„­€€  €‡‡€š

(37)

32/b 38 39 41 66/b

70 71 72 74/A

3/89 95

  €Œ€† ˆ ›Ž…

¨€ ˆ …‡  …†† ˆ€ † …†ž

™™

™

ARTICLE /

PARAGRAPH NUMBER TEXT OF THE ARTICLE / PARAGRAPH REASONS FOR NOT APPLYING The Board of Directors holds at least four meetings a year -

no less than one meeting every three [3] months

This Paragraph is an Indicative Paragraph This paragraph contradicts what is stated in Article (24) of the company's articles of association

Determining the conditions that must be met by the secretary

This Article is an Indicative Article The secretary is appointed in accordance with Article (23) of the company’s articles of association

Training the board members and executive management This Article is an Indicative Article Training the board members and executive management This Article is an Indicative Article

The number of candidates for the Board of Directors This Paragraph is an Indicative Paragraph Formation of the Risk Management Committee

Terms of reference of the Risk Management Committee Meetings of the Risk Management Committee

This Articles are an Indicative Articles The company’s management continuously reviews the company’s policies related to risk management to ensure that the approved policies and programs are implemented in order to reduce the risks that the company may face.

The senior management of the company also ensures that the risk management processes and the followed systems operate efficiently at all levels of the company.

Establishing an independent unit or department to assess and manage risks

The company is currently searching for the necessary competencies at the appropriate cost to establish this unit as soon as possible, taking into account the comment mentioned on the above articles.

That the company's website includes all the information required to be disclosed, and any data or other information

published through other means of disclosure

This Paragraph is an Indicative ParagraphThe company shall publish any information and data required to be disclosed in accordance with the laws and regulations in the manner specified by the Capital Market Authority.

Forming the Corporate Governance Committee This Article is an Indicative ArticleThe company develops corporate governance rules, monitors their implementation, verifies their effectiveness, and modifies them when needed.

(38)

†ƒ€„ˆ††£†ˆ‚

2020 2021 PERCENTAGE

OF TOTAL REVENUE PERCENTAGE OF

TOTAL REVENUE

69 57

%6

 €

 

COMPANY REVENUE - A VALUE IN MILLION

2020 2021 PERCENTAGE

OF TOTAL REVENUE PERCENTAGE OF

TOTAL REVENUE REVENUE OF THE SUBSIDIARY -

THE VALUE WILL BE IN MILLION

  %9

œžŸ

578 186 764

738 214 952

%75.7

%24.3

%100

%77.5

%22.5

%100

(39)

THE MAIN ELEMENTS OF THE INCOME STATEMENT

THE VALUE WILL BE IN MILLION

€

Œ‡

†‡

‡

†€ ­‰‹  „–”“    „†…­ŠŠ „“‚”°„

 ¦  „ « … „ ˆ

 €‚

€  „… €†§ ‡  ­„

­•  „‰    „‰– „“‚•°„‚

€   ˆ¥ ­†…

‹¡’

(40)

 …†ˆ †… „ ˆ  ƒ¥‡ †—­’•­’ ­™

€Ž¢ … ˆ

‡ € ­–„ ­Š ­‰ˆ€ˆ … †

€ˆ  †‚

€

€

Œ‡

Œ‡

†‡

‡ˆ«›

‡

ITEM / YEAR 2017 2018 2019 2020 2021

952 364 131 118 90 764

253 109 84 131 974

283 147 109 93 894

250 138 105 90 709

239 143 123 108

(41)

ˆ ††§€€†…†

†„ …†§¨†ˆ …

 ¥††§€‚

Ž    ‡   ­Š  ­‰  

†¨ ††

 «„ †¨‡

¨‚

Ž‡ ­

€ † ­ˆ†

¨ˆ€¨

      … ¥ 

†   ‚ ‰ — 

 ¥ 

„…… ‡€

¥ ­‚† 

 ˆ †…  †

¥ˆ€‚

The Value will be in MILLION

†

‡

‡ˆ

«›

‡

(42)

¢

ƒ˜

ƒ˜

•

™œ

The Value will be in MILLION

2019 2020 2021

2017 2018

2,262 602 1,659 2,262 2,435

736 1,699 2,435 2,538

972 1,566 2,538 2,484

1,006 1,478 2,484 2,303

916 1,387 2,303

2017 2018 2019 2020 2021

2,538 2,484

2,303 2,262

2,435

(43)

The Value will be in MILLION

™œ

2017 2018 2019 2020 2021

1,006 972 916

ƒ˜

1,566 1,478

1,387

¢

602

1,659 736

1,699

(44)

€ˆ † …  ­–Ž ­‰†… …†§¨†„…›

† ­Š„‚†  «¥ €

‚ˆ¥¢ ­Š‚§€ 

€  ¥ ­… ‚ 

•‹° „…€   ¨„ †

§ ¨†ˆ€‚

 ƒ¥†…•Š–‚­   ­–”‹‰‚­   ­„¨  °‚›†

ˆ‡‰    ­–„”     –   ­‚

The Value will be in MILLION

™œ

ƒ˜

2017 2018 2019 2020 2021

2,538 2,484

2,303 2,435 2,262

(45)

 …†ˆ «ª…—­’•­’ ­Œ™€‡€ž

‰Š

‹­ƒ­ Œ‹ Ž   ‹­ƒ Ž Œ‹ Ž   ‹­ƒ‘‹ Œ‹ Ž  

‹Œ ‹ „Œ  Œˆ­ ˆ­

ЉŠ

‰Š

‰

’‰‰

ITEM / YEAR

The Value will be in MILLION

™œ

2019

2017 2018 2020 2021

435 (133) (195) 107

14 121 328

(27) (363)

(62) 76 14 183

(45) (106)

32 44 76 (52)

(117) 35 (134)

178 44 310

(197) 52 165

13 178

0 50 100 150 200 250 300 350 400

183

45 106

32 44 76 310

197

52 165

13 178

328

27 363

62 76 14

435

133 195

107

14 121 52

117

35 134

178

44

(46)

…ƒ † ˆ‡ †€

„ˆ€ˆ©€ Œ ˆ ˆ

„›†€ƒ‡  †ˆ

€† † ˆŸ‡†ˆ›„… ¨

ˆ „¥¨ ‚† ‚—““™—“‹™ƒ „

€ „ ¨†„ˆ‡ …ž

€ €¨ˆˆˆ…—” °ŽŠ °™‡„ 

…‡ „ €‚

ˆ † † ˆ „…ž±€ «†

ˆ¥ € „…‡† †ˆ ˆ„›† €‚²

‡ˆˆ ˆ ‡ˆ

„…ˆ‚

“””•

’

“”–•

Š

’

 ‡ˆ† † ¨

 …ž

—­ °™‡¨ €‚Œ

ˆ ¨…€  ‚

ށŒ ˆ „ „†

‡€‚

ށ„‡¥ —‹°™Ž ˆˆŽ

„ˆˆ€ † ˆ ‚

ށˆ  ‡„†

€ Œ ˆ ‚

(47)

Љ’

’

Š

The Value will be in MILLION

2019 2020 2021

2017 2018

90 120

72

%80 131

120 60

%46 93

120 -

%0 90

120 -

%0 108

120 90

%83

2017 2018 2019 2020 2021

108 93

131

90 90

(48)

ˆ

ˆ‚

ˆ„

 ˆ ˆ‚

††

† …ˆ    

…€†‡‚

††

† …ˆ ˆ  ˆ  

¨€…€ ‚

†— ­Œ™„›

€€ˆ‡

ƒ ‚

†‡ †—­’•­’ ­Œ™

ˆ ††—ˆˆ„

¨€„ ™†

†ˆ €‚

†— ­Œ™Ž†

ˆ€ˆ 

„ ˆ † „  †„

ˆ‚

†— ­Œ™Ž†

ˆ†ˆ

€ˆ „ „ˆ

†„ †‚

Referensi

Dokumen terkait

The settlement of the distribution of gonorrhea assets in court is regulated in Article 35 paragraph 1 and Article 37 of the Marriage Law which states that: Article 35 paragraph 1